Table 1.
Clinical characteristics of the patients with MACS
| Mean | Standard Deviation | Minimum-maximum | |
|---|---|---|---|
| Age (years) | 55.7 | 9.8 | 33-68 |
| Gender (F/M) | 25/2 (92.6%) | ||
| IOP (mmHg) | 14.6 | 1.8 | 12-20 |
| Axial length (µm) | 22.6 | 0.3 | 22.2-23.4 |
| 1 mg DST (µg/dl) | 3.3 | 1.4 | 1.90-8.50 |
| 2 mg LDDT (µg/dl) | 3.6 | 1.8 | 2.0-9.7 |
| LNSC (µg/L) | 0.26 | 0.19 | 0.05-0.89 |
| UFC (µg/24h) | 90.8 | 40.9 | 42-210 |
| PFC (µg/dl) | 14.8 | 2.9 | 9.30-20 |
| ACTH (ng/L) | 7.3 | 2.3 | 4.4-11.5 |
| DHEA-S (n, %) | 4/27 (14.8%) | ||
| Follow-up time (years) | 2.8 | 2 | 1-8 |
| HbA1c (%) | 5.8 | 0.5 | 5-7 |
| Hypertension (n, %) | 15/27 (55.6%) | ||
| PreDM, DM (n, %) | 14/27 (51.8%) | ||
| Osteoporosis (n, %) | 7/27 (25.9%) | ||
| Mass size (mm) | 24.2±6.3 | 15-38 |
MACS: Mild autonomous cortisol secretion; IOP: Intraocular pressure; DST: Dexamethasone supression test; LDDT: Low dose 2-day 2 mg dexamethasone suppression test; LNSC: Late night salivary cortisol; UFC: 24-hour total urine-free cortisol; PFC: Morning plasma free cortisol.